Cargando…

Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report

INTRODUCTION: The use of the drug infliximab for the treatment of patients with Crohn's disease can be complicated by tuberculosis. A paradoxical reaction during antituberculosis chemotherapy and immunologic reconstitution after discontinuation of infliximab can result in severe disseminated tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Young Kyung, Kim, Jeong Yeon, Sohn, Jang Wook, Kim, Min Ja, Koo, Ja Seol, Choi, Jai Hyun, Park, Dae Won
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Case report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726479/ https://www.ncbi.nlm.nih.gov/pubmed/19830122 http://dx.doi.org/10.1186/1752-1947-3-6673

Ejemplares similares

Paradoxical Tuberculomas after Completion of Antituberculous Treatment
por: Shah, Ira, et al.
Publicado: (2012)

CONTRA-LATERAL PARADOXICAL PLEURAL EFFUSION DURING ANTITUBERCULOUS CHEMOTHERAPY
por: Chopra, Vishal, et al.
Publicado: (2008)

A Case of Obstructive Jaundice Caused by Paradoxical Reaction during Antituberculous Chemotherapy for Abdominal Tuberculosis
por: Lee, Yun Jung, et al.
Publicado: (2009)

A Newly Developed Pericardial Tuberculoma During Antituberculous Therapy
por: Kim, Sang Min, et al.
Publicado: (2011)

Early monitoring for detection of antituberculous drug-induced hepatotoxicity
por: Lee, Chang Min, et al.
Publicado: (2016)

Antituberculous Serum
Publicado: (1899)

On Treatment with Antituberculous Serum
Publicado: (1904)

Acute respiratory distress during paradoxical reaction to antituberculous therapy in an 8-month-old child
por: Shah, Ira, et al.
Publicado: (2012)

263 Clinical Features of Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculous Medications
por: Kim, Sang-Ha, et al.
Publicado: (2012)

Nosocomial Outbreak of Carbapenem-Resistant Acinetobacter baumannii in Intensive Care Units and Successful Outbreak Control Program
por: Choi, Won Suk, et al.
Publicado: (2010)

Epidemiological and Genetic Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from the Ear Discharge of Outpatients with Chronic Otitis Media
por: Yang, Jin Ah, et al.
Publicado: (2008)

Epidemiology and Control of an Outbreak of Vancomycin-Resistant Enterococci in the Intensive Care Units
por: Yoon, Young Kyung, et al.
Publicado: (2009)

A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA
por: Min, Ji-Yeon, et al.
Publicado: (2012)

Impact of immunopathology on the antituberculous activity of pyrazinamide
por: Blanc, Landry, et al.
Publicado: (2018)

Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis
por: Seok, Hyeri, et al.
Publicado: (2019)

Correction to: Characteristics of residual lymph nodes after six months of antituberculous therapy in HIV-negative individuals with cervical tuberculous lymphadenitis
por: Seok, Hyeri, et al.
Publicado: (2019)

Molecular Analysis of Isoleucyl-tRNA Synthetase Mutations in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus with Low-Level Mupirocin Resistance
por: Yang, Jin Ah, et al.
Publicado: (2006)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

AdDRESSing T-cell responses to antituberculous drugs
por: Pavlos, R., et al.
Publicado: (2017)

Renal BCGosis managed conservatively with antituberculous medications
por: Elmekresh, Amr, et al.
Publicado: (2023)

Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
por: Yoon, Young Kyung, et al.
Publicado: (2014)

New onset or exacerbation of uveitis with infliximab: paradoxical effects?
por: Iwahashi, Chiharu, et al.
Publicado: (2019)

Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions
por: Marais, Ben J, et al.
Publicado: (2020)

Bromocriptine for Control of Hyperthermia in a Patient with Mixed Autonomic Hyperactivity after Neurosurgery: A Case Report
por: Kang, Seong Hee, et al.
Publicado: (2012)

1499. Distribution and Clinical Implication of Isolation of Multidrug-Resistant Microorganisms in Patients with Intra-Abdominal Infections
por: Kyung Yoon, Young, et al.
Publicado: (2019)

Treatment of severe psoriasis with infliximab
por: Leman, JA, et al.
Publicado: (2008)

The role of smart monitoring digital health care system based on smartphone application and personal health record platform for patients diagnosed with coronavirus disease 2019
por: Kim, Jong Hun, et al.
Publicado: (2021)

Tuberculosis associated thrombocytopenic purpura: effectiveness of antituberculous therapy
por: Borie, Raphael, et al.
Publicado: (2009)

ANTITUBERCULOUS IMMUNITY IN MICE VACCINATED WITH KILLED TUBERCLE BACILLI
por: Dubos, René J., et al.
Publicado: (1953)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Management of Severe Gastrointestinal Tuberculosis with Injectable Antituberculous Drugs
por: Goldani, Luciano Z., et al.
Publicado: (2015)

Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
por: Choi, Chang Hwan, et al.
Publicado: (2016)

Cold Snare Polypectomy in Patients Taking Dual Antiplatelet Therapy: A Randomized Trial of Discontinuation of Thienopyridines
por: Won Ma, Dae, et al.
Publicado: (2019)

Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
por: Nakamura, Akihiro, et al.
Publicado: (2016)

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy
por: Sheikh, Javaid A, et al.
Publicado: (2011)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use
por: Kang, Ho Suk, et al.
Publicado: (2019)

Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports
por: Xia, Ping, et al.
Publicado: (2021)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k3scr6v8o05m1lrui66m47t8um